TEOFARMA

TEOFARMA, trading as Teofarma S.r.l., is a privately held Italian pharmaceutical company from the Pavia area, south of Milan. It does not present itself as a beauty house. Instead, the company describes its business as owning and marketing pharmaceutical brands and holding the official licences that allow those products to be sold [3]. Most of what it sells is medicines and dietary supplements under their own product names, but the TEOFARMA name also appears on a small number of pharmacy skincare items, such as an ointment for the face and hands.

The company is active. Its website carries a 2026 copyright notice and an open call for job applicants, and an Italian business database reports revenue of roughly €345 million for 2024 [7]. Its founding date is reported differently depending on the source: the company places it in the late 1980s, while a French online pharmacy gives 1999.

In its own words, Teofarma was "established in the late 80's in Pavia, close to Milan" [3]. The company gives no exact year, and no founders are named publicly. A French online pharmacy tells a different story, stating that the laboratory was founded in Italy in 1999 [6]; the same page credits it with more than two decades of experience. This article follows the company's own dating to the late 1980s, while noting that the precise year has not been confirmed.

Descriptions of where the company sits also vary in detail. Teofarma says only that it is in Pavia. The UK's electronic medicines compendium, the French reference database Vidal and an Italian business register all give an address on Via Fratelli Cervi in Valle Salimbene, in the province of Pavia [10]. A Portuguese medicines index, by contrast, lists a street address in the city of Pavia itself [11].

Teofarma is organised as a società a responsabilità limitata, the Italian form of limited-liability company. Beyond its description of itself as private, no owners or parent company are named in public sources.

Teofarma publishes no mission statement, tagline or brand philosophy. What it does spell out is its business model. The company says it "owns and markets pharmaceutical Brands and holds the related Marketing Authorizations" [3]. A marketing authorization is the licence a medicine needs before it can be sold, so holding it makes the company the party responsible for each product, not simply a reseller.

The public face of the company reflects that professional focus. Its homepage is a login page rather than a showroom: access is restricted to health personnel, with a notice citing a directive issued by the Italian Ministry of Health on 22 March 2000 [2]. The pages listing products, active ingredients and therapeutic areas sit behind the same login. The site itself runs in Italian, English, French, Spanish and German.

The careers page offers a rare look at how the business works from the inside. Teofarma recruits machine operators for production and packaging lines, laboratory analysts, maintenance technicians, and staff for regulatory affairs and pharmacovigilance, the monitoring of side effects after a medicine reaches the market [4]. It also seeks graduates in law, business, medicine, mathematics and statistics for roles supporting mergers and acquisitions, several of them requiring at least five years of experience. The company has not publicly named any brands it has bought.

An Italian business ranking site classifies Teofarma under the manufacture of pharmaceutical products and preparations, reports 151 employees, and places it first in its ranking for the province of Pavia [7]. The same profile shows revenue climbing from about €250 million in 2019 to €345 million in 2024. Profit moved far less steadily over those years: around €65 million in 2019, a small loss of about €1.7 million in 2023, and roughly €76 million in 2024.

Teofarma's portfolio is built mostly from medicines sold under individual brand names rather than under the company name. The UK's electronic medicines compendium lists twelve of its licensed medicines [10]. They include Coracten capsules (nifedipine), Dioctyl (docusate sodium), Liskonum (lithium carbonate), Mintec (peppermint oil), Prothiaden (dosulepin) and the Ferrograd iron tablets, which come in plain, vitamin C and folic acid versions.

Elsewhere, the range leans toward over-the-counter products and supplements. A French online pharmacy groups Teofarma's products around iron and vitamin deficiencies, eye health and dry eyes, digestion, and the nervous system and sleep [6]. Its examples include the Fero-grad Vitamine C 500 iron product, Nicobion 500 mg (vitamin PP, also known as niacin), Larmes Artificielles Martinet artificial tears, the digestive supplement Rabro Actif and Glicero Valerovit Neo for sleep. Vidal, the French reference database, lists an anti-fatigue oral solution called Actiphos Neo [9].

The company's clearest link to skincare is Biancardi Special Ointment, a 40 ml product sold under the TEOFARMA name by a Spanish online pharmacy [8]. The retailer describes it as an ointment that helps clarify, tone and renew facial skin and fade blemishes, for use on the face or the hands. Its ingredients are not stated. Beyond this ointment, the product lines named in public listings are medicines and dietary supplements.

No proprietary technologies, patents, research partnerships or third-party certifications are documented for the company.

TEOFARMA is an operating company. Its website shows a 2026 copyright line, and its careers page was recruiting across production, regulatory and acquisition roles in 2026. The most recent reported financial year is 2024, when revenue reached about €345 million. In Portugal, the logistics firm ALOGA-LOGIFARMA, based in Terrugem-Sintra, is named as the company's distribution partner [11].